Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LAMIVUDINE\ZIDOVUDINE for Hepatitis b: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 10 adverse event reports in the FDA FAERS database where LAMIVUDINE\ZIDOVUDINE was used for Hepatitis b.

Most Reported Side Effects for LAMIVUDINE\ZIDOVUDINE

Side Effect Reports % Deaths Hosp.
Foetal exposure during pregnancy 622 23.8% 101 71
Maternal exposure during pregnancy 284 10.9% 6 30
Exposure during pregnancy 280 10.7% 9 27
Virologic failure 231 8.9% 6 2
Drug resistance 147 5.6% 0 8
Viral mutation identified 145 5.6% 0 4
Premature baby 144 5.5% 13 34
Pathogen resistance 137 5.3% 0 12
Anaemia 130 5.0% 10 50
Abortion spontaneous 119 4.6% 3 1
Lipodystrophy acquired 98 3.8% 0 23
Treatment noncompliance 96 3.7% 1 15
Premature delivery 85 3.3% 2 11
Low birth weight baby 78 3.0% 4 9
Exposure during breast feeding 74 2.8% 39 1

Other Indications for LAMIVUDINE\ZIDOVUDINE

Hiv infection (1,475) Product used for unknown indication (438) Antiretroviral therapy (143) Maternal exposure timing unspecified (86) Prophylaxis against hiv infection (59) Acquired immunodeficiency syndrome (54) Hiv infection cdc category c (32) Foetal exposure during pregnancy (28) Hiv test positive (21) Antiviral treatment (15)

Other Drugs Used for Hepatitis b

TENOFOVIR DISOPROXIL (2,088) ENTECAVIR (1,583) LAMIVUDINE (1,057) TENOFOVIR ALAFENAMIDE (935) ADEFOVIR DIPIVOXIL (792) EMTRICITABINE\TENOFOVIR DISOPROXIL (301) TENOFOVIR (200) PEGINTERFERON ALFA-2A (166) TELBIVUDINE (111) GLECAPREVIR\PIBRENTASVIR (98)

Related Pages

LAMIVUDINE\ZIDOVUDINE Full Profile All Hepatitis b Drugs LAMIVUDINE\ZIDOVUDINE Demographics LAMIVUDINE\ZIDOVUDINE Timeline